Detailed answers about STRATEGIC DRUG DEVELOPMENT LTD, including incorporation, status, business activity, and accounts information.
When was STRATEGIC DRUG DEVELOPMENT LTD founded?
STRATEGIC DRUG DEVELOPMENT LTD was officially incorporated on 4 February 2026 and is registered under company number 17012324. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is STRATEGIC DRUG DEVELOPMENT LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of STRATEGIC DRUG DEVELOPMENT LTD?
STRATEGIC DRUG DEVELOPMENT LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does STRATEGIC DRUG DEVELOPMENT LTD do?
STRATEGIC DRUG DEVELOPMENT LTD operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is STRATEGIC DRUG DEVELOPMENT LTD's registered address?
The registered office address of STRATEGIC DRUG DEVELOPMENT LTD is 6 FOXGLOVE CLOSE, CHERTSEY, ENGLAND, KT16 8FD. This is the official address filed with Companies House for legal and statutory correspondence.
Is STRATEGIC DRUG DEVELOPMENT LTD financially stable?
Financial accounts for STRATEGIC DRUG DEVELOPMENT LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.